MiNK Therapeutics Narrows Third-Quarter Losses and Achieves First Revenue
INKT MiNK Therapeutics Inc
$10.22 +2.14%
View chart & analysis → - 1MiNK Therapeutics recorded a positive surprise rate of 24.2% for the third quarter.
- 2MiNK Therapeutics reported third-quarter revenue of $0.2 million.
- 3Management emphasized that operating cash burn was lowest at approximately $1.3 million in 2026.
So what's the key point?
MiNK Therapeutics reduced its losses and generated revenue for the first time in the third quarter. The results were better than what experts expected, indicating an improvement in the company's situation.
Source Earnings Whispers · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.